![]() |
![]() ALSO SPONSORED BY: ![]()
Wine Industry Insight |
![]() |
The National Institutes of Health says it has halted a $100 million industry-funded moderate drinking study whose origins were first revealed in 2014 by Wine Industry Insight reporting.
NIH Director Francis Collins told a Senate subcommittee yesterday said that enrollment in the Moderate Alcohol and Cardiovascular Health (MACH15) study had been halted a on May 12 as part of an internal investigation about ethical concerns over the funding sources and how the money was solicited.
Collins said: “For NIH, our reputation is so critical. And if we are putting ourselves in a circumstance where that could be called into question, I felt like we had to look at that very seriously and come up with another strategy.
The statement was made in testimony before the Senate Appropriations Subcommittee on Health and Human Services and Related Agencies regarding its 2019 budget request for the research centers.
In March, NIH announced its intention to investigate the funding process.
On Feb 28, 2014, WII was the first to report that the National Institute of Alcohol Abuse and Alcoholism (NIAAA) was soliciting funds from the alcoholic beverage industry — US Govt Asking Industry To Fund Most Of $50 Million Alcohol/Health Study.
That study, a massive, multi-year investigation, was headed by Kenneth J. Mukamal, an Associate Professor of Medicine and General Internist at Beth Israel Deaconess Medical Center in Boston.
According to documents obtained in 2014 by Wine Industry Insight, beer and spirits companies agreed to support the study. The Wine Institute was solicited for support but did not participate.
In the fall of 2017, Wine Industry Insight received a request from the New York Times and shared the full text of its premium article. On March 17, 2018, the New York Times published a piece with updated details on the solicitation of industry funds by NIH scientists — Federal Agency Courted Alcohol Industry to Fund Study on Benefits of Moderate Drinking
Subsequently, the details of the study were available online by the NIH and formed the basis for two additional articles from Wine Industry Insight: